跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ICATIBANT INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ICATIBANT INJECTION
Authorized
STANDARD
ICATIBANT INJECTION
Accord Healthcare Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ba26a78f3fab277b
Company
Accord Healthcare Inc
Type
Standard
Approval Details
Approval Id
ba26a78f3fab277b
Drug Approval Canada Name
ICATIBANT INJECTION
Product Name
ICATIBANT INJECTION
Status
Cancelled Pre Market
Status Date
2025-06-09
Din
02516608
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
92:32.00
Atc Original
B06AC02 ICATIBANT
Atc Name
b 06 ac 02
Aig Number
0155710001
Company Name
Accord Healthcare Inc
Company Address
3535 Boulevard St-Charles, Suite 704, Kirkland, Quebec, Canada, H9H 5B9
Company Detail Path
/organization/accord-healthcare-inc
Company Information
Pharmaceutical Company Name
Accord Healthcare Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
704-3535 boul Saint-Charles
Active Ingredients
ICATIBANT (ICATIBANT ACETATE)
30 MG / 3 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ba26a78f3fab277b
Type
Standard
Back to Health Canada Approvals